A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
Patrick M DillonGina R PetroniMark E SmolkinDavid R BreninKimberly A Chianese-BullockKelly T SmithWalter C OlsonIbrahim S FanousCarmel J NailChristiana M BreninEmily H HallCraig L SlingluffPublished in: Journal for immunotherapy of cancer (2017)
ClinicalTrials.gov (posted 2/15/2012): NCT01532960. Registered 2/8/2012. https://clinicaltrials.gov/show/NCT01532960.